Market Overview

The Vietnam point of care molecular diagnostics market size reached USD 41.10 Million in 2024 and is projected to reach USD 80.02 Million by 2033, growing at a CAGR of 6.89% during 2025-2033. The market growth is propelled by the expansion of advanced PCR and isothermal amplification technologies, government healthcare modernization initiatives, and international partnerships facilitating rapid molecular diagnostics adoption across provincial networks.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Vietnam Point of Care Molecular Diagnostics Market Key Takeaways

• Current Market Size: USD 41.10 Million in 2024
• CAGR: 6.89%
• Forecast Period: 2025-2033
• The market is driven by rapid adoption of advanced PCR and isothermal amplification technologies in decentralized healthcare.
• Government initiatives include national disease detection programs like the Double X tuberculosis screening strategy combining chest radiography with GeneXpert testing.
• Integration of AI-enhanced diagnostic interpretation improves disease detection, especially in remote and underserved areas.
• International partnerships with USAID and WHO support technology transfer and sustainable implementation of rapid molecular diagnostics.
• Digital health integration enables real-time surveillance and coordination across healthcare delivery levels.

Sample Request Link: https://www.imarcgroup.com/vietnam-point-of-care-molecular-diagnostics-market/requestsample

Market Growth Factors

Vietnam has been integrating advanced point-of-care (POC) molecular testing technology into its health care system. Portable PCR machines, isothermal nucleic acid amplification platforms and microfluidic lab-on-a-chip systems have been set up at over 200 sites across the country, which provide lab-level molecular testing at the point of care. Molecular platforms can provide rapid testing for tuberculosis and other infectious diseases in one hour, while providing accurate results. In chest radiography, artificial intelligence-based analysis of the images and subsequent interpretation can improve diagnostic accuracy and support pattern recognition and appear to be of help to clinicians with less expertise.

Vietnam's government has invested heavily in improving the molecular diagnosis of TB by establishing nationally coordinated systems of disease surveillance, and made the Double X strategy (chest radiography followed by rapid GeneXpert molecular testing) the National TB Screening Strategy for Vietnam. The high yield of symptomatic to asymptomatic case finding in PHC (provincial health care organizations) will drive the growth of the market, as initiatives to end the HIV/AIDS epidemic by 2030 will be undertaken. Digital health systems enable real-time surveillance, evidence-based clinical decision-making, and coordination across levels of care, especially through deconcentration of diagnostics at health stations at the commune level.

With partners including USAID, WHO, and major diagnostics companies, TB Alliance is rapidly transferring technology and easing the development of locally appropriate point-of-care molecular diagnostic technologies, such as low-cost battery powered devices for on-site and same-day TB and drug-resistant TB diagnosis in less than two hours, and ultra-portable digital X-ray systems, with computer vision software to read the images without a radiologist. Equipment and training, continuing technical support and capacity building can sustain these partnerships and on this basis Vietnam can remain a regional leader in point-of-care molecular diagnostics innovation.

Market Segmentation

Product and Service Insights:

• Assays and Kits: Consumable materials essential for conducting molecular diagnostic tests.
• Instruments and Analyzers: Devices and equipment used to perform molecular diagnostic procedures.
• Software and Services: Digital tools and support services facilitating diagnostics and data management.

Technology Insights:

• Polymerase Chain Reaction (PCR): Technology for amplifying DNA sequences to detect pathogens.
• Hybridization: Techniques involving binding of nucleic acid probes to target sequences for detection.
• DNA Sequencing: Methods for determining the exact order of nucleotides in DNA.
• Microarray: Platforms for analyzing gene expression or genetic variation.
• Isothermal Nucleic Acid Amplification Technology (INAAT): Amplification methods operating at constant temperature.
• Others: Additional molecular diagnostic technologies not specifically classified.

Application Insights:

• Infectious Diseases: Use of diagnostics for detecting infections caused by various pathogens.
• Oncology: Diagnostic applications for cancer detection and monitoring.
• Hematology: Diagnostics related to blood diseases and disorders.
• Prenatal Testing: Assessing fetal health and genetic disorders during pregnancy.
• Endocrinology: Diagnostics related to hormone-related diseases.
• Others: Other medical diagnostic applications.

End User Insights:

• Physicians' Offices: Medical practices where molecular diagnostics are utilized.
• Hospitals and ICUs: Larger healthcare facilities and intensive care units using these diagnostics.
• Research Institutes: Organizations conducting biomedical research with molecular diagnostic tools.
• Others: Other end users of molecular diagnostic services.

Regional Insights

Northern Vietnam, Central Vietnam, and Southern Vietnam are the key regional markets covered. Among these, specific dominant regional statistics such as market share or CAGR are not provided in the source text. The report includes comprehensive analysis of these three Vietnamese regions, underpinning the market's regional segmentation.

Recent Developments & News

In December 2024, the International Center for Interdisciplinary Science and Education (ICISE) announced The Third Rencontres de Quy Nhon, the International Conference on Molecular Diagnostics in Microbiology and Diseases (MDMD 2025), scheduled for December 11 to 13, 2025, in Quy Nhon City, Binh Dinh Province, Vietnam.

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Request For Customization: https://www.imarcgroup.com/request?type=report&id=42843&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302